A5084467687- Cerebral Venous Sinus Thrombosis
- Retinal and Optic Conditions
- Corneal surgery and disorders
- Retinopathy of Prematurity Studies
- Sinusitis and nasal conditions
- Pharmacological Effects and Toxicity Studies
- Intraocular Surgery and Lenses
- Retinal Diseases and Treatments
- Neonatal Respiratory Health Research
- Ophthalmology and Eye Disorders
- Ocular Disorders and Treatments
- Epilepsy research and treatment
- Bacterial Infections and Vaccines
- Connective tissue disorders research
- Retinal and Macular Surgery
- Anatomy and Medical Technology
- Aortic aneurysm repair treatments
- Facial Nerve Paralysis Treatment and Research
- Dermatological diseases and infestations
- Brain Metastases and Treatment
- Infectious Diseases and Tuberculosis
- Pituitary Gland Disorders and Treatments
- Ocular Oncology and Treatments
- Neurological Disorders and Treatments
- Surgical Simulation and Training
Loma Linda University
2018-2024
Loma Linda University Medical Center
2019-2024
University of New Mexico
2015-2021
University of Iowa
2013-2014
University of Iowa Hospitals and Clinics
2013
University of Miami
2013
Oklahoma State University Medical Center
2008
University of Southern California
2007
Doheny Eye Institute
2007
<h3>Importance</h3> Previous studies of<i>myo</i>-inositol in preterm infants with respiratory distress found reduced severity of retinopathy prematurity (ROP) and less frequent ROP, death, intraventricular hemorrhage. However, no large trials have tested its efficacy or safety. <h3>Objective</h3> To test the adverse events to reduce type 1 ROP among younger than 28 weeks' gestational age. <h3>Design, Setting, Participants</h3> Randomized clinical trial included 638 age enrolled from 18...
The aims of this study were to evaluate visual function outcomes in idiopathic intracranial hypertension (IIH) patients who underwent ventriculoperitoneal (VP) shunt for loss and determine a VP survival curve over time.A retrospective medical record review was performed all new IIH first evaluated at our institution placement 7-year period (2004-2010). There 2 primary outcome measures: the being acuity (VA) second survival. Patients received included analysis, any reason analysis.Of 338 with...
Visual impairment in children with brain tumors has received limited attention, as most pediatric neuro-oncology clinical trials neither require ophthalmologic evaluation on enrollment nor monitor effects of treatment visual function during and after treatment.To investigate ophthalmology referral patterns for primary tumors, the prevalence sequelae, association between tumor characteristics vision-related diagnoses.This retrospective cohort study included 141 treated at Loma Linda...
A 8 year-old female with sickle cell disease diagnosed at birth was confirmed to have neurofibromatosis type 1 13 months of age. At 7 years old, she noted incidental papilledema subsequent workup showing elevated opening pressure. She intracranial hypertension and began treatment acetazolamide the discontinuation hydroxyurea. Acetazolamide tapered off hydroxyurea restarted no worsening in her ophthalmologic exam. We report this case due rare occurrence all three conditions as well delineate...
A pediatric female with sickle cell disease (SCD) and neurofibromatosis type 1 was noted to have incidental papilledema, subsequent workup showing an elevated opening pressure. She diagnosed intracranial hypertension began treatment acetazolamide. Hydroxyurea also discontinued. Acetazolamide tapered off, hydroxyurea restarted no worsening in her ophthalmologic exam. We report this case due the rare occurrence of all 3 conditions, while has been reported SCD, diagnostic for papilledema...
Objective: To report a case of progressive ataxia with supranuclear palsy attributed to Anti-Ma2 antibodies, despite immunotherapy and treatment the underlying malignancy. Background: Anti-Ma2-related paraneoplastic syndrome is characterized by limbic, diencephalic or brainstem encephalitis, alone in combination. In young males, this highly associated germ cell tumors, presenting MRI abnormalities as well abnormal CSF EEG studies. Management includes malignancy immunotherapy. Methods: Case...
Objective: To report a case of severe, bilateral vision loss and complete ophthalmoplegia in patient with elevated intracranial pressure (EIP) subsequent improvement motility after stenting right transverse sinus stenosis. Background: Elevated ICP is known to cause loss, abducens nerve palsy, rarely oculomotor trochlear palsies. Severe dysmotility both eyes all gazes has not been reported. Venous stenosis postulated as possible pathophysiologic mechanism underlying the setting idiopathic...
Congenital optic nerve anomalies often lead to significant visual impairment. Their prevalence is rising with an increasing ability diagnose and classify each specific malformation. These are associated several neurologic, systemic, ophthalmologic features which may predict a patient's prognosis help physicians identify treatment plans. Here, we briefly review congenital anomalies, their unique presentations, clinical considerations.